Clinical Trial: Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Schizophrenia
Study Type: INTERVENTIONAL
Official Title: A Randomized Controlled Trial to Evaluate Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
Brief Summary:
Schizophrenia is a serious mental disorder with a global prevalence of 1%.The main cause of this condition is dysfunction in the signaling of neurotransmitters dopamine, serotonin, glutamate and Gamma-aminobutyric acid .According to recent research, a disturbed cellular energy state caused by mitochondrial dysfunction is thought to be a factor in the development of schizophrenia.The aim of the treatment of schizophrenia is to reduce symptoms and is mainly based on the monoamine hypothesis.Atypical antipsychotics…
Read more